PACS CEO Jason Hulse Murray Sells $651K of Stock
Key Points
- Jason Hulse Murray, Co-Founder and CEO, sold 13,696 shares for about $651,211 on October 22, 2026.
- Following this sale, Murray holds 54,257,117 shares, a slight decrease of 0.03% in his ownership.
- PACS Group has a market cap of approximately $7.54 billion and a P/E ratio of 27.86.
Since the trade, $PACS is up 0.3% to date (from the $47.50 close on Oct 22, 2026).
Get PACS Group text alerts
We text you when insiders, Congress, analysts or big funds move on $PACS.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated PACS Group, Inc. alert may contain errors. Disclosures
On October 22, 2026, Jason Hulse Murray, the Co-Founder, CEO, and Chairman of PACS Group, Inc. (NYSE: PACS), sold 13,696 shares at a price of $47.55 each, amounting to about $651,210.56. This transaction was reported through a Form 4 filing with the SEC.
Murray's latest sale brings his total ownership to 54,257,117 shares, reflecting a minor decrease of 0.03%. This sale follows a series of insider trades by Murray earlier in the month, where he sold 1,620 shares on October 19, 37,477 shares on October 20, and 6,610 shares on October 21.
PACS
PACS Group, Inc.
Other Institutional Activity in PACS
Several other institutional investors have also been active with PACS Group. Crewe Advisors LLC increased its stake by 553,034 shares, totaling 3,307,188 shares valued at approximately $161.3 million. American Century Companies Inc. added 1,298,580 shares to its holdings, bringing its total to 3,108,196 shares worth about $151.6 million. Conversely, Cohen & Steers Inc. trimmed its position by 780,054 shares, leaving it with 8,343,381 shares valued at around $406.8 million.
PACS Group, Inc. Stock Up 2.7%
PACS Group closed at $47.50 on October 22, 2026. Recently, the stock has been trading around $48.76 as of October 26, which is about 2.7% higher than its closing price on the day of Murray's sale. The stock is currently above its 50-day moving average by 11.5% and its 200-day moving average by 23.4%. However, it remains slightly below its 52-week high of $49.49.
Recent Earnings
PACS Group reported trailing twelve-month revenue of approximately $5.55 billion, with an EPS of $1.71. The company's revenue growth year-over-year stands at 9.1%. The next earnings report is scheduled for November 9, 2026.
Dividend
PACS Group does not currently pay a dividend.
Insider Buying and Selling at PACS Group, Inc.
In addition to the recent sale, Jason Hulse Murray has been active in selling shares throughout October. On October 16, he sold 8,462 shares, valued at about $402,876, followed by another sale of 16,620 shares on October 19 for approximately $77,060. On October 20, he sold 37,477 shares worth around $1.79 million, and on October 21, he sold 6,610 shares for roughly $314,755. All these transactions were part of planned sales.
Analysts Set New Price Targets
Analysts have maintained positive ratings on PACS Group. On August 6, 2026, UBS rated the stock as a Buy with a target price of $60. RBC Capital also maintained an Outperform rating with a target of $57, while Truist Securities set a Buy rating with a target of $62. The consensus target price among analysts is $59, with six analysts contributing opinions.
About PACS Group
PACS Group, Inc. operates skilled nursing and assisted living facilities across the United States. Founded in 2013 and based in Salt Lake City, Utah, the company is involved in acquiring and managing healthcare-related properties.
Bottom Line
Looking ahead, investors should keep an eye on the upcoming earnings report on November 9, 2026, as well as any further insider trading activity from Murray. Additionally, the consensus among analysts remains strong with a target price significantly above the current trading levels.
Related Filing Alerts
Source: Jason Hulse Murray's Form 4 filing on $PACS (Oct 22, 2026). Written by software, not financial advice. How we make alerts